<DOC>
	<DOCNO>NCT02706834</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability single oral dos TAK-828 healthy non-Japanese Japanese participant .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics Escalating Single Doses TAK-828 Healthy Participants</brief_title>
	<detailed_description>The drug test study call TAK-828 . TAK-828 test evaluate safety , tolerability , pharmacokinetic ( PK ) pharmacodynamic ( PD ) single oral dos TAK-828 healthy non-Japanese Japanese participant . The study enroll approximately 36 healthy participant . An interleaving crossover design placebo substitution use Cohorts 1-3 . Each cohort consist 12 participant , randomly assign ( chance , like flip coin ) treatment sequence receive TAK-828 placebo undergo fasting stage least 8 hour intervention period 1-4 Cohorts 1 2 intervention period 1 - 3 Cohort 3 . The assigned treatment sequence remain undisclosed participant study doctor study ( unless urgent medical need ) . An additional interventional period 5 ( feed state ) plan conduct either cohort 1 2 , base dose TAK-828 chosen study fed condition . Cohorts 1 2 conduct non-Japanese participant Cohort 3 Japanese participant . This multi-center trial conduct The United States . Participants remain confined study site check-in ( Day -1 ) Day 4 intervention period return 7 10 day last dose study drug follow-up assessment .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>1 . Is healthy male female ( nonchild bear potential ) participant . 2 . Cohorts 1 2 : nonJapanese participant age 18 55 year , inclusive , body mass index ( BMI ) 18 30 kilogram per square meter ( kg/m^ 2 ) , inclusive , body weight great equal ( &gt; = ) 50 kilogram ( kg ) . 3 . Cohort 3 : Japanese participant ( bear Japanese parent grandparent ) age 20 55 year , inclusive , BMI 18.5 25 kg/m^ 2 , inclusive , body weight &gt; = 45 kg . 1 . Has use prescription nonprescription drug dietary supplement within 7 day 5 halflives ( whichever longer ) prior Checkin ( Day 1 ) . Herbal supplement hormone replacement therapy ( HRT ) must discontinue 28 day prior Checkin ( Day 1 ) . As exception , acetaminophen may use dos less equal ( &lt; = ) 1 gram per day ( g/day ) . Limited use nonprescription medication believe affect participant safety overall result study may permit casebycase basis follow approval sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Drug therapy</keyword>
</DOC>